Exos 25 is an Aromasin (Exemestane) is a drug of the aromatase inhibitor group that reduces the production of estrogen in the body. This drug is approved in the USA and is used in the treatment of breast cancer.
In bodybuilding, Aromasin (Exemestane) is used on a steroid cycle to reduce the aroma effect (conversion of testosterone to estrogen) when taking anabolic hormonal preparations.
Effects of Aromasin (Exemestane)
- Gynecomastia prophylaxis
- Decreased estrogen production (by 97%)
- Increased anabolic hormone levels
- Improved muscle relief
- Prevention of hypertension
- Reduction of estrogen suppression of the hypothalamus-pituitary-testes axis
Side Effects of Aromasin (Exemestane)
Excess dosages and abuse of aromatase inhibitors lead to excessive suppression of estrogen production and the following effects:
- Inhibition of muscle growth
- Fall libido
- Increased cholesterol
- Joint pain
- Bone Strength Reduction
Side Effects of Aromasin (Exemestane):
- Increased risk of fractures (60%)
- Joint pain
- Formation of arterial and venous blood clots
- Dryness of the mucous membranes of the urogenital area
Important! When using any pharmacological agents, it is recommended to consult a doctor.
Dosage and cycle of Aromasin (Exemestane)
For side effects prevention (in bodybuilding): 12.5 mg every other day.
For the treatment of gynecomastia: 25 mg every day until the symptoms disappear (12.5 mg every day).
Usage at a cycle of steroids:
When using steroids with a short half-life (testosterone propionate, methandienone): after 10 days of the cycle, take an estradiol test and take 12.5 mg of Aromasin (Exemestane) every other day. Next, after 10 days, once again pass tests for estradiol and adjust the dosage of Aromazine (Exemestane) according to their results.
When using steroids with long esters (enanthate, sustanon, cypionate): after 3-4 weeks of the cycle, take tests for estradiol and take 12.5 mg of Aromasin (Exemestane) every other day. Next, after 10 days, once again pass tests for estradiol and adjust the dosage of Aromazine (Exemestane) according to their results.